Clinical Trial Update: Management of Mandibular ORN: PENTO as Medical Treatment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating PENTO (pentoxifylline and vitamin E) as medical treatment for mandibular osteoradionecrosis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoradionecrosis

Drugs mentioned

• Pentoxifylline (pentoxifylline)
• Vitamin E (tocopherol)

Snippet

Sponsor: Hospital Vall d'Hebron | Conditions: Osteoradionecrosis | Phase 4 | Status: COMPLETED | Results posted: 2016-12-20